Overview

Multiple Dose Trial Comparing the Plasma Levels of Two Different Analgesic Transdermal Patch Formulations (Protocol ID: 855509)

Status:
Terminated

Trial end date:
2007-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether two different analgesic transdermal patch formulations lead to same plasma levels of active ingredient after multiple dose application.

Phase:

Phase 1

Details

Lead Sponsor:

Grünenthal GmbH

Treatments:

Analgesics
Buprenorphine